WLP has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
WLP has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.166 |
WLP's Cash to Debt is ranked lower than
88% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 1.88 vs. WLP: 0.166 ) |
WLP'
s 10-Year Cash to Debt Range
Min: 0.17 Max: 0.57 Current: 0.17 |
| Equity to Asset | -0.048 |
WLP's Equity to Asset is ranked lower than
76% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 0.20 vs. WLP: -0.048 ) |
WLP'
s 10-Year Equity to Asset Range
Min: -0.05 Max: 0.35 Current: -0.05 |
| Interest Coverage | 7.6 |
WLP's Interest Coverage is ranked higher than
76% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 265.90 vs. WLP: 7.6 ) |
WLP'
s 10-Year Interest Coverage Range
Min: 7 Max: 18 Current: 7.6 |
| F-Score: 4 |
|
| Z-Score: 1.97 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 6.30 |
WLP's Operating margin (%) is ranked higher than
71% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 4.00 vs. WLP: 6.30 ) |
WLP'
s 10-Year Operating margin (%) Range
Min: 5.1 Max: 11.4 Current: 6.3 |
| Net-margin (%) | 4.3 |
WLP's Net-margin (%) is ranked higher than
71% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 2.10 vs. WLP: 4.3 ) |
WLP'
s 10-Year Net-margin (%) Range
Min: 0.4 Max: 7.3 Current: 4.3 |
| ROE (%) | 11.2 |
WLP's ROE (%) is ranked higher than
59% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 9.20 vs. WLP: 11.2 ) |
WLP'
s 10-Year ROE (%) Range
Min: 2.7 Max: 19.1 Current: 11.2 |
| ROA (%) | 4.5 |
WLP's ROA (%) is ranked higher than
65% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 2.80 vs. WLP: 4.5 ) |
WLP'
s 10-Year ROA (%) Range
Min: 0.9 Max: 9.1 Current: 4.5 |
| ROC (Joel Greenblatt) (%) | 6357.70 |
WLP's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 86.80 vs. WLP: 6357.70 ) |
WLP'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 669.7 Max: 6357.7 Current: 6357.7 |
| Revenue Growth (%) | 8.9 |
WLP's Revenue Growth (%) is ranked higher than
88% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 7.35 vs. WLP: 8.9 ) |
WLP'
s 10-Year Revenue Growth (%) Range
Min: 0 Max: 12.9 Current: 8.9 |
| EBITDA Growth (%) | -2.4 |
WLP's EBITDA Growth (%) is ranked higher than
76% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 14.00 vs. WLP: -2.4 ) |
WLP'
s 10-Year EBITDA Growth (%) Range
Min: 0 Max: 19.5 Current: -2.4 |
| EPS Growth (%) | -4.6 |
WLP's EPS Growth (%) is ranked higher than
59% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 13.10 vs. WLP: -4.6 ) |
WLP'
s 10-Year EPS Growth (%) Range
Min: 0 Max: 19.7 Current: -4.6 |
| David Einhorn 1,930,689 sh (New) Daniel Loeb 850,000 sh (New) Steven Cohen 999,189 sh (+56.93%) Jean-Marie Eveillard 6,762,157 sh (+21.03%) Joel Greenblatt 11,842 sh (+7.4%) First Pacific Advisors 2,673,400 sh (+3.99%) Steven Romick 2,395,000 sh (+3.68%) | John Hussman 800,000 sh (unchged) Bernard Horn 36,600 sh (unchged) Dodge & Cox 6,000 sh (unchged) Vanguard Health Care Fund 7,902,400 sh (unchged) Tom Russo 204 sh (unchged) Alan Fournier 2,827,892 sh (unchged) | George Soros Sold Out Louis Moore Bacon Sold Out Jeff Auxier 65,421 sh (-0.23%) Pioneer Investments 3,467 sh (-0.86%) Leon Cooperman 2,043,727 sh (-2.13%) James Barrow 11,750,325 sh (-2.31%) Jeremy Grantham 554,197 sh (-5.84%) Paul Tudor Jones 7,900 sh (-27.52%) Ray Dalio 10,316 sh (-88.81%) |
| Donald Yacktman 3,518,467 sh (New) HOTCHKIS & WILEY 1,828,100 sh (New) Richard Snow 997,902 sh (New) Ray Dalio 148,537 sh (+1339.87%) Joel Greenblatt 23,595 sh (+99.25%) Paul Tudor Jones 12,100 sh (+53.16%) James Barrow 17,288,330 sh (+47.13%) Daniel Loeb 1,250,000 sh (+47.06%) Alan Fournier 3,299,892 sh (+16.69%) First Pacific Advisors 2,674,000 sh (+0.02%) | Steven Romick 2,395,000 sh (unchged) Yacktman Fund 1,350,000 sh (unchged) Bernard Horn 36,600 sh (unchged) Yacktman Focused Fund 1,600,000 sh (unchged) Tom Russo 204 sh (unchged) | Pioneer Investments Sold Out Vanguard Health Care Fund 7,702,400 sh (-2.53%) Jeff Auxier 63,571 sh (-2.83%) Jeremy Grantham 507,297 sh (-8.46%) Jean-Marie Eveillard 6,133,756 sh (-9.29%) Dodge & Cox 5,000 sh (-16.67%) Leon Cooperman 1,285,527 sh (-37.1%) John Hussman 500,000 sh (-37.5%) David Einhorn 958,173 sh (-50.37%) Steven Cohen 22,912 sh (-97.71%) |
| Chris Davis 4,050 sh (New) Steven Cohen 311,800 sh (+1260.86%) HOTCHKIS & WILEY 4,456,671 sh (+143.79%) James Barrow 18,130,049 sh (+4.87%) Yacktman Fund 1,406,800 sh (+4.21%) Donald Yacktman 3,621,535 sh (+2.93%) Paul Tudor Jones 12,400 sh (+2.48%) Jean-Marie Eveillard 6,189,156 sh (+0.9%) | Tom Russo 204 sh (unchged) Yacktman Focused Fund 1,600,000 sh (unchged) Jeremy Grantham 459,646 sh (unchged) Vanguard Health Care Fund 7,702,400 sh (unchged) Bernard Horn 36,600 sh (unchged) | David Einhorn Sold Out Daniel Loeb Sold Out Leon Cooperman 1,282,127 sh (-0.26%) Jeff Auxier 62,771 sh (-1.26%) Alan Fournier 3,189,292 sh (-3.35%) Richard Snow 960,264 sh (-3.77%) Steven Romick 2,025,000 sh (-15.45%) First Pacific Advisors 2,260,700 sh (-15.46%) Dodge & Cox 4,000 sh (-20%) John Hussman 339,000 sh (-32.2%) Ray Dalio 50,912 sh (-65.72%) Joel Greenblatt 3,468 sh (-85.3%) |
| Tom Gayner 50,000 sh (New) Bruce Kovner 85,000 sh (New) John Burbank 7,586 sh (New) Paul Tudor Jones 330,500 sh (+2565.32%) Chris Davis 7,880 sh (+94.57%) Jeff Auxier 63,471 sh (+1.12%) Jean-Marie Eveillard 6,238,556 sh (+0.8%) Donald Yacktman 3,640,189 sh (+0.52%) | Bernard Horn 36,600 sh (unchged) Yacktman Focused Fund 1,600,000 sh (unchged) Tom Russo 204 sh (unchged) Dodge & Cox 4,000 sh (unchged) Vanguard Health Care Fund 7,702,400 sh (unchged) Steven Romick 2,025,000 sh (unchged) First Pacific Advisors 2,260,700 sh (unchged) Yacktman Fund 1,406,800 sh (unchged) | John Hussman Sold Out Ray Dalio Sold Out Leon Cooperman Sold Out Alan Fournier Sold Out Joel Greenblatt Sold Out James Barrow 17,860,497 sh (-1.49%) Richard Snow 944,898 sh (-1.6%) Jeremy Grantham 386,414 sh (-15.93%) HOTCHKIS & WILEY 3,347,698 sh (-24.88%) Steven Cohen 86,962 sh (-72.11%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Leon Cooperman | 2013-03-31 | Sold Out | 1.4% | $58.93 - $66.28 | $ 77.81 | 23% | 0 | |
| John Hussman | 2013-03-31 | Sold Out | 0.54% | $58.93 - $66.28 | $ 77.81 | 23% | 0 | |
| HOTCHKIS & WILEY | 2013-03-31 | Reduce -24.88% | 0.4% | $58.93 - $66.28 | $ 77.81 | 23% | 3347698 | |
| Tom Gayner | 2013-03-31 | New Buy | 0.12% | $58.93 - $66.28 | $ 77.81 | 23% | 50000 | |
| Ray Dalio | 2013-03-31 | Sold Out | 0.03% | $58.93 - $66.28 | $ 77.81 | 23% | 0 | |
| John Burbank | 2013-03-31 | New Buy | 0.02% | $58.93 - $66.28 | $ 77.81 | 23% | 7586 | |
| Joel Greenblatt | 2013-03-31 | Sold Out | 0.01% | $58.93 - $66.28 | $ 77.81 | 23% | 0 | |
| Chris Davis | 2013-03-31 | Add 94.57% | $58.93 - $66.28 | $ 77.81 | 23% | 7880 | ||
| Daniel Loeb | 2012-12-31 | Sold Out | 1.4% | $54.33 - $63.03 | $ 77.81 | 32% | 0 | |
| HOTCHKIS & WILEY | 2012-12-31 | Add 143.79% | 0.94% | $54.33 - $63.03 | $ 77.81 | 32% | 4456671 | |
| David Einhorn | 2012-12-31 | Sold Out | 0.93% | $54.33 - $63.03 | $ 77.81 | 32% | 0 | |
| John Hussman | 2012-12-31 | Reduce -32.2% | 0.23% | $54.33 - $63.03 | $ 77.81 | 32% | 339000 | |
| Ray Dalio | 2012-12-31 | Reduce -65.72% | 0.08% | $54.33 - $63.03 | $ 77.81 | 32% | 50912 | |
| Joel Greenblatt | 2012-12-31 | Reduce -85.3% | 0.08% | $54.33 - $63.03 | $ 77.81 | 32% | 3468 | |
| Chris Davis | 2012-12-31 | New Buy | $54.33 - $63.03 | $ 77.81 | 32% | 4050 | ||
| Richard Snow | 2012-09-30 | New Buy | 3.2% | $52.95 - $64.31 | $ 77.81 | 32% | 997902 | |
| Donald Yacktman | 2012-09-30 | New Buy | 1.2% | $52.95 - $64.31 | $ 77.81 | 32% | 3518467 | |
| Leon Cooperman | 2012-09-30 | Reduce -37.1% | 1.08% | $52.95 - $64.31 | $ 77.81 | 32% | 1285527 | |
| David Einhorn | 2012-09-30 | Reduce -50.37% | 0.96% | $52.95 - $64.31 | $ 77.81 | 32% | 958173 | |
| James Barrow | 2012-09-30 | Add 47.13% | 0.64% | $52.95 - $64.31 | $ 77.81 | 32% | 17288330 | |
| HOTCHKIS & WILEY | 2012-09-30 | New Buy | 0.63% | $52.95 - $64.31 | $ 77.81 | 32% | 1828100 | |
| Daniel Loeb | 2012-09-30 | Add 47.06% | 0.45% | $52.95 - $64.31 | $ 77.81 | 32% | 1250000 | |
| John Hussman | 2012-09-30 | Reduce -37.5% | 0.36% | $52.95 - $64.31 | $ 77.81 | 32% | 500000 | |
| Ray Dalio | 2012-09-30 | Add 1339.87% | 0.11% | $52.95 - $64.31 | $ 77.81 | 32% | 148537 | |
| Joel Greenblatt | 2012-09-30 | Add 99.25% | 0.05% | $52.95 - $64.31 | $ 77.81 | 32% | 23595 | |
| David Einhorn | 2012-06-30 | New Buy | 1.9% | $65.15 - $73.13 | $ 77.81 | 13% | 1930689 | |
| Daniel Loeb | 2012-06-30 | New Buy | 1.7% | $65.15 - $73.13 | $ 77.81 | 13% | 850000 | |
| Jean-Marie Eveillard | 2012-06-30 | Add 21.03% | 0.3% | $65.15 - $73.13 | $ 77.81 | 13% | 6762157 | |
| Ray Dalio | 2012-06-30 | Reduce -88.81% | 0.1% | $65.15 - $73.13 | $ 77.81 | 13% | 10316 | |
| George Soros | 2012-06-30 | Sold Out | 0.07% | $65.15 - $73.13 | $ 77.81 | 13% | 0 |
More recent guru trades are included for Premium Members only!!
| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 9.20 |
WLP's P/E(ttm) is ranked higher than
88% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 10.80 vs. WLP: 9.20 ) |
WLP'
s 10-Year P/E(ttm) Range
Min: 4.33 Max: 36.99 Current: 9.2 |
| P/B | 0.99 |
WLP's P/B is ranked higher than
82% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 1.50 vs. WLP: 0.99 ) |
WLP'
s 10-Year P/B Range
Min: 0.71 Max: 4.21 Current: 0.99 |
| P/S | 0.38 |
WLP's P/S is ranked lower than
59% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 0.40 vs. WLP: 0.38 ) |
WLP'
s 10-Year P/S Range
Min: 0.26 Max: 1.33 Current: 0.38 |
| PFCF | 12.45 |
WLP's PFCF is ranked lower than
71% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 13.43 vs. WLP: 12.45 ) |
WLP'
s 10-Year PFCF Range
Min: 5.86 Max: 50.97 Current: 12.45 |
| EV-to-EBIT | 9.85 |
WLP's EV-to-EBIT is ranked lower than
65% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 7.65 vs. WLP: 9.85 ) |
WLP'
s 10-Year EV-to-EBIT Range
Min: 2.9 Max: 33.9 Current: 9.85 |
| PEG | 0.59 |
WLP's PEG is ranked higher than
71% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 0.80 vs. WLP: 0.59 ) |
WLP'
s 10-Year PEG Range
Min: 0.29 Max: 1.77 Current: 0.59 |
| Shiller P/E | 10 |
WLP's Shiller P/E is ranked higher than
71% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 12.40 vs. WLP: 10 ) |
WLP'
s 10-Year Shiller P/E Range
Min: 6.81 Max: 22.88 Current: 10 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Dividend Yield | 1.59 |
WLP's Dividend Yield is ranked higher than
88% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 1.40 vs. WLP: 1.59 ) |
WLP'
s 10-Year Dividend Yield Range
Min: 0.31 Max: 2.02 Current: 1.59 |
| Dividend Payout | 0.2 |
WLP's Dividend Payout is ranked higher than
76% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 0.13 vs. WLP: 0.2 ) |
WLP'
s 10-Year Dividend Payout Range
Min: 0.14 Max: 0.14 Current: 0.2 |
| Yield on cost (5-Year) | 1.60 |
WLP's Yield on cost (5-Year) is ranked higher than
71% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 1.55 vs. WLP: 1.60 ) |
WLP'
s 10-Year Yield on cost (5-Year) Range
Min: 0.31 Max: 2.02 Current: 1.6 |
| Share Buyback Rate | 9.3 |
WLP's Share Buyback Rate is ranked higher than
94% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 0.70 vs. WLP: 9.3 ) |
WLP'
s 10-Year Share Buyback Rate Range
Min: 0 Max: -26.6 Current: 9.3 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 6.7 |
WLP's Price/Net Current Asset Value is ranked lower than
71% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 10.10 vs. WLP: 6.7 ) |
WLP'
s 10-Year Price/Net Current Asset Value Range
Min: 5.6 Max: 15.1 Current: 6.7 |
| Price/DCF (Projected) | 0.4 | ||
| Price/Median PS Value | 0.7 |
WLP's Price/Median PS Value is ranked lower than
76% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 0.70 vs. WLP: 0.7 ) |
WLP'
s 10-Year Price/Median PS Value Range
Min: 0.6 Max: 2.2 Current: 0.7 |
| Price/Peter Lynch Fair Value | 0.6 |
WLP's Price/Peter Lynch Fair Value is ranked higher than
65% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 0.80 vs. WLP: 0.6 ) |
WLP'
s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.5 Max: 1.1 Current: 0.6 |
| Earnings Yield (Greenblatt) | 10.20 |
WLP's Earnings Yield (Greenblatt) is ranked lower than
53% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 13.60 vs. WLP: 10.20 ) |
WLP'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.9 Max: 34.7 Current: 10.2 |
| Forward Rate of Return (Yacktman) | 21.4 |
WLP's Forward Rate of Return (Yacktman) is ranked higher than
71% of the 17 Companies in the Global Health Care Plans industry. ( Industry Median: 20.32 vs. WLP: 21.4 ) |
WLP'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: 15.5 Max: 29.5 Current: 21.4 |
| Industry: | Health Care Plans | |
|---|---|---|
| Compare: | UNH, ESRX, HUM, AET, CI | |
| Traded in other countries: | AE1.Germany |
| THC to Refinance Senior Notes - Analyst Blog May 17 2013 - ZACKS |